SCHEMBL6160526

SCHEMBL6160526

NC1CCC(Cc2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.59
CCR3 P51677 3/20 0.53
PRMT3 O60678 1/20 0.53
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
PRMT1 Q99873 1/20 0.53
PRMT8 Q9NR22 1/20 0.53
SIGMAR1 Q99720 3/20 0.47
TMEM97 Q5BJF2 1/20 0.47
GRIN2B Q13224 2/20 0.47
MGLL Q99685 1/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4203449 1.00 GBA1 (0.59) GBA1CCR3PRMT3CARM1PRMT6
Hydrochloric Acid SCHEMBL30304790 0.98 GBA1 (0.57) GBA1CCR3PRMT3CARM1PRMT6
Hydrochloric Acid SCHEMBL29210829 0.98 GBA1 (0.57) GBA1CCR3PRMT3CARM1PRMT6
SCHEMBL674276 0.89 GBA1 (0.71) GBA1CCR3PRMT3CARM1PRMT6
SCHEMBL2027845 0.89 GBA1 (0.71) GBA1CCR3PRMT3CARM1PRMT6
SCHEMBL13936369 0.88 GBA1 (0.50) GBA1CCR3PRMT3CARM1PRMT6
SCHEMBL3898572 0.88 GBA1 (0.50) GBA1CCR3PRMT3CARM1PRMT6
Ammonia Solution, Strong SCHEMBL1432566 0.86 GBA1 (0.68) GBA1CCR3PRMT3CARM1PRMT6
Hydrochloric Acid SCHEMBL4797146 0.84 GBA1 (0.65) GBA1CCR3PRMT3CARM1PRMT6
SCHEMBL5525774 0.83 GBA1 (0.59) GBA1CCR3PRMT3CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122542-A1 PROCESS TO PRODUCE (1R,4R)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES RICHTER GEDEON NYRT (HU) 2025-04-17 US disclosed
EP-4402276-A1 PROCESS TO PRODUCE (1 R, 4 R)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES Richter Gedeon Nyrt. (HU) 2024-07-24 EP disclosed
CN-118043471-A Process for the production of (1 r,4 r) -4-substituted cyclohexane-1-amines 吉瑞工厂 2024-05-14 CN disclosed
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS TRINEURO (KR) 2024-01-18 US disclosed
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS TRINEURO (KR) 2024-01-18 US disclosed
WO-2023042081-A1 PROCESS TO PRODUCE (1r,4r)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES RICHTER GEDEON NYRT. (HU) 2023-03-23 WO disclosed
CN-104859223-A Adhesive-free FCCL (flexible copper-clad laminate) with two medium layers CHENGDU DO IT NEW MATERIAL CO LTD 2015-08-26 CN disclosed
CN-104842625-A Preparation method of two-layer dielectric adhesive-free flexible copper clad laminate CHENGDU DO IT NEW MATERIAL CO LTD 2015-08-19 CN disclosed
CN-103087066-A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith PHARMACOPEIA DRUG DISCOVERY 2013-05-08 CN disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed
WO-2001032634-A1 2-CYCLOHEXYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed
US-6204260-B1 2-(AZETIDIN-2-ON-1-YL)ACETIC ACID DERIVATIVES ELI LILLY AND COMPANY 2001-03-20 US disclosed
EP-0743936-B1 CYCLOHEXANE DERIVATIVES AS VOLTAGE-GATED POTASSIUM CHANNEL BLOCKERS WYETH JOHN & BROTHER LTD (GB) 2000-06-14 EP disclosed
US-5948881-A LOW VISCOSITY, HIGH DRYING SPEED, EPOXY RESINS/POLYEPOXIDES AIR PRODUCTS AND CHEMICALS, INC. (US) 1999-09-07 US disclosed
US-5852023-A Cyclohexylamino and cycloalkoxy nitrogen heterocycles, processes for their preparation, and their use as pesticides and fungicides HOECHST SCHERING AGREVO GMBH (DE) 1998-12-22 US disclosed
EP-0817774-A1 CYCLOHEXYLAMINO AND CYCLOHEXYLALKOXY NITROGEN HETEROCYCLES, METHODS OF PREPARING THEM AND THEIR USE AS PEST-CONTROL AGENTS AND FUNGICIDES Hoechst Schering AgrEvo GmbH (DE) 1998-01-14 EP disclosed
WO-1996030345-A1 CYCLOHEXYLAMINO AND CYCLOHEXYLALKOXY NITROGEN HETEROCYCLES, METHODS OF PREPARING THEM AND THEIR USE AS PEST-CONTROL AGENTS AND FUNGICIDES HOECHST SCHERING AGREVO GMBH (DE) 1996-10-03 WO disclosed
US-4041053-A DYES OR INTERMEDIATES THEREFOR BAYER AKTIENGESELLSCHAFT (DT) 1977-08-09 US disclosed
US-3980677-A Anthraquinone dyestuffs containing sulphonic acid groups BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 GBA1 1191/4885CCR3 2998/4885PRMT3 3162/4885
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS MAOA, DRD2, MAOB GBA1 1662/4885CCR3 4856/4885PRMT3 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.